Surmodics - 21 Year Stock Price History | SRDX

Historical daily share price chart and data for Surmodics since 1998 adjusted for splits. The latest closing stock price for Surmodics as of November 11, 2019 is 39.08.
  • The all-time high Surmodics stock closing price was 80.35 on September 13, 2018.
  • The Surmodics 52-week high stock price is 61.72, which is 57.9% above the current share price.
  • The Surmodics 52-week low stock price is 38.06, which is 2.6% below the current share price.
  • The average Surmodics stock price for the last 52 weeks is 46.46.
Surmodics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 45.2256 46.4100 58.3500 38.2300 39.0800 -17.31%
2018 51.6426 28.3500 80.3500 27.0000 47.2600 68.79%
2017 26.6009 25.9000 33.2000 22.5000 28.0000 10.24%
2016 23.6679 18.9900 30.4200 17.6200 25.4000 25.31%
2015 23.3890 22.1100 27.2600 20.1800 20.2700 -8.28%
2014 21.7201 24.2600 25.7900 18.1200 22.1000 -9.39%
2013 23.7374 23.2100 27.5500 19.7400 24.3900 9.08%
2012 16.9313 14.5200 22.3600 13.6900 22.3600 52.52%
2011 11.9297 11.8300 15.4000 8.8600 14.6600 23.50%
2010 15.7546 23.0000 23.0000 8.3300 11.8700 -47.62%
2009 22.2163 25.9900 30.6900 16.0100 22.6600 -10.33%
2008 38.5238 54.2800 54.2800 19.7000 25.2700 -53.44%
2007 43.4585 32.0500 56.7400 31.1100 54.2700 74.39%
2006 35.4589 37.3700 40.2200 31.1000 31.1200 -15.87%
2005 37.1368 31.5500 46.1300 28.0800 36.9900 13.78%
2004 23.8372 24.0800 32.9000 18.6000 32.5100 36.94%
2003 30.2065 29.4900 41.0500 20.1000 23.7400 -17.22%
2002 33.1802 35.8000 46.5000 19.9500 28.6800 -21.34%
2001 41.7589 31.5000 59.3700 23.2500 36.4600 -0.95%
2000 19.2425 15.2500 36.8100 10.0000 36.8100 145.40%
1999 7.7664 6.8750 16.0000 4.9375 15.0000 93.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.527B $0.100B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.090B 27.01
Medtronic (MDT) Ireland $143.599B 20.16
Stryker (SYK) United States $74.738B 25.13
Boston Scientific (BSX) United States $56.464B 26.65
Baxter (BAX) United States $40.084B 24.31
EssilorLuxottica Societe Anonyme (ESLOY) France $32.664B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.619B 18.58
Terumo (TRUMY) Japan $27.722B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.691B 0.00
Coloplast (CLPBY) Denmark $25.121B 0.00
ResMed (RMD) United States $20.684B 38.16
Sunny Optical Technology (SNPTF) China $18.592B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.588B 0.00
Bio-Rad Laboratories (BIO) United States $10.550B 50.64
Insulet (PODD) United States $10.476B 498.41
Canopy Growth (CGC) Canada $7.475B 0.00
Hill-Rom Holdings (HRC) United States $6.947B 20.47
Perrigo (PRGO) Ireland $6.812B 12.70
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.037B 40.79
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.155B 0.00
Aurora Cannabis (ACB) Canada $3.920B 0.00
NuVasive (NUVA) United States $3.757B 29.59
ICU Medical (ICUI) United States $3.456B 22.41
GW Pharmaceuticals (GWPH) United Kingdom $3.380B 0.00
Neogen (NEOG) United States $3.369B 56.38
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.987B 0.00
Quidel (QDEL) United States $2.480B 23.54
National Vision Holdings (EYE) United States $2.179B 49.55
Agios Pharmaceuticals (AGIO) United States $1.976B 0.00
Cardiovascular Systems (CSII) United States $1.570B 0.00
InMode (INMD) Israel $1.293B 0.00
Aphria (APHA) $1.275B 0.00
VAREX IMAGING (VREX) United States $1.245B 28.70
AtriCure (ATRC) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $0.936B 17.53
Eagle Pharmaceuticals (EGRX) United States $0.863B 22.01
Lantheus Holdings (LNTH) United States $0.842B 21.04
NanoString Technologies (NSTG) United States $0.826B 0.00
TG Therapeutics (TGTX) United States $0.775B 0.00
Omeros (OMER) United States $0.669B 0.00
LeMaitre Vascular (LMAT) United States $0.662B 37.49
PetIQ (PETQ) United States $0.655B 16.01
HEXO (HEXO) $0.604B 0.00
Quanterix (QTRX) United States $0.589B 0.00
Cerus (CERS) United States $0.577B 0.00
Organigram Holdings (OGI) Canada $0.572B 0.00
OraSure Technologies (OSUR) United States $0.529B 31.74
Owens & Minor (OMI) United States $0.454B 16.79
MacroGenics (MGNX) United States $0.404B 0.00
Utah Medical Products (UTMD) United States $0.383B 27.79
BioLife Solutions (BLFS) United States $0.341B 104.75
Meridian Bioscience (VIVO) United States $0.337B 11.62
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.328B 0.00
Zynex (ZYXI) United States $0.295B 33.33
Viemed Healthcare (VMD) United States $0.266B 0.00
Bovie Medical (APYX) United States $0.238B 0.00
United Health Products (UEEC) United States $0.185B 0.00
Vapotherm (VAPO) United States $0.183B 0.00
Repro-Med Systems (KRMD) United States $0.172B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
InfuSystems Holdings (INFU) United States $0.142B 0.00
Liberty Health Sciences (LHSIF) Canada $0.133B 0.00
Female Health (VERU) United States $0.131B 0.00
Fonar (FONR) United States $0.126B 8.87
Rockwell Medical (RMTI) United States $0.118B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.085B 21.62
Chembio Diagnostics (CEMI) United States $0.080B 0.00
Nephros (NEPH) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
MRI Interventions (MRIC) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.048B 0.00
MTech Acquisition (KERN) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00